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Abstract
Osteoarthritis (OA) is a common disease in the elderly due to an imbalance in cartilage degradation and synthesis.
Heterotopic ossification (HO) occurs when ectopic masses of endochondral bone form within the soft tissues around the
joints and is triggered by inflammation of the soft tissues. Procyanidin B3 (B3) is a procyanidin dimer that is widely studied
due to its high abundance in the human diet and antioxidant activity. Here, we evaluated the role of B3 isolated from grape
seeds in the maintenance of chondrocytes in vitro and in vivo. We observed that B3 inhibited H2O2-induced apoptosis in
primary chondrocytes, suppressed H2O2- or IL-1ß2induced nitric oxide synthase (iNOS) production, and prevented IL-
1ß2induced suppression of chondrocyte differentiation marker gene expression in primary chondrocytes. Moreover, B3
treatment enhanced the early differentiation of ATDC5 cells. To examine whether B3 prevents cartilage destruction in vivo,
OA was surgically induced in C57BL/6J mice followed by oral administration of B3 or vehicle control. Daily oral B3
administration protected articular cartilage from OA and prevented chondrocyte apoptosis in surgically-induced OA joints.
Furthermore, B3 administration prevented heterotopic cartilage formation near the surgical region. iNOS protein expression
was enhanced in the synovial tissues and the pseudocapsule around the surgical region in OA mice fed a control diet, but
was reduced in mice that received B3. Together, these data indicated that in the OA model, B3 prevented OA progression
and heterotopic cartilage formation, at least in a part through the suppression of iNOS. These results support the potential
therapeutic benefits of B3 for treatment of human OA and heterotopic ossification.
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Introduction
Osteoarthritis (OA) is a common disease in the elderly due to an
imbalance in cartilage degradation and synthesis. In OA, articular
chondrocytes appear to be eliminated by apoptosis [1–3]. The
number of apoptotic cells in articular cartilage is significantly
higher in OA patients than in healthy subjects. In response to
cytokine stimulation, articular chondrocytes can produce a variety
of reactive oxygen species (ROS), including peroxynitrite, super-
oxide anions, nitric oxide (NO), and hydrogen peroxide (H2O2)
[4–6]. IL-1b induces chondrocyte death only when used in
combination with oxygen radical scavengers or with a CD95
agonist [7,8]. The apoptosis-enhancing pathway induced by IL-1b
depends on the generation of ROS [8]. Primary OA chondrocytes
show both spontaneous and inducible levels of lipid peroxidation
activity [9]. Thus, ROS are among the key inflammatory
mediators involved in chondrocyte apoptosis observed in OA.
H2O2 induces apoptosis in many cell types and may mediate
cartilage degeneration associated with inflammatory joint diseases
that induce chondrocyte apoptosis [10,11].
NO has been increasingly recognized as a signaling intermedi-
ate of IL-12induced responses in many cell types [4,12], including
chondrocytes [13,14]. NO also regulates aggrecanase activity and
induces aggrecan degeneration in chondrocytes [15]. Endoge-
nously synthesized NO reduces cartilage proteoglycan synthesis in
response to cytokines such as IL-1 [13]. IL-1 plays a pivotal role in
the pathophysiology of OA by inducing a cascade of inflammatory
and catabolic events, including the synthesis of prostaglandin E2
(PGE2) and NO. IL-1 also alters chondrocyte anabolism by
suppressing the synthesis of extracellular matrix (ECM) compo-
nents, such as proteoglycan and type II collagen, and by
enhancing the production of matrix metalloproteinases (MMPs)
[13].
Heterotopic ossification (HO) occurs when ectopic masses of
endochondral and intramembranous bone form within the soft
tissue and muscle around joints, in subcutaneous tissues, and in
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loss of motion, and impaired function. A number of recent studies
have shown that there is an increased rate of HO in patients with
serious injuries and head trauma [17]. A safe and effective primary
prophylaxis for HO is under clinical investigation [18].
Grape seed proanthocyanidins (GSP) are powerful antioxidant
polyphenols [19,20], and various epidemiologic and in vivo/in vitro
experimental studies [21–23] have suggested that proanthocyani-
dins derived from fruits, vegetables, and beverages might decrease
the risk of several lifestyle diseases. Recent studies have shown that
proanthocyanidins have various therapeutic properties, such as
radical scavenging, and exhibit a number of health benefits,
including antiulcer, antiallergy, antidental caries, and antitumor
activity. In addition, proanthocyanidins may inhibit food allergies,
activate hair follicle growth, and protect cells from ultraviolet
radiation [24–30].
Proanthocyanidins are obtained from many kinds of plants as
a complex mixture of structurally related components. The
structural diversity of polyphenols makes it difficult to determine
the biological properties of individual components. The absorption
of polyphenols also depends on their molecular weight. Because of
their large molecular weight, proanthocyanidin polymers are likely
not as easily absorbed by the small intestine. A major portion of
ingested polyphenols (75–99%) is not detected in the urine,
whereas procyanidin dimers are detected in the serum of rats and
humans after GSP ingestion [31,32]. Procyanidin B3 (B3) is
a procyanidin dimer that is widely studied due to its abundance in
the human diet [33–35]. B3 and other procyanidin dimers can be
absorbed by the small intestine [36] and have relevant antioxidant
activities [37]. In the present study, we evaluated the role of B3
isolated from grape seed extracts in the differentiation and survival
of chondrocytes in vitro. Furthermore, the potential ability of B3 to
protect articular cartilage in vivo and prevent HO was estimated
using a surgically-induced osteoarthritis model.
Materials and Methods
Reagents
B3 was isolated in the laboratory from proanthocyanidin-rich
grape seed extracts, which contained 82% proanthocyanidins,
provided by Kikkoman Co. (Chiba, Japan). Isolation was carried
out according to the method by Zhao et al. [33]. Briefly, B3 was
purified using reverse and normal phase HPLC. The isolated B3
was characterized by NMR and HPLC/MS, and the purity was
determined to be 97% by HPLC/UV.
Animals
C57BL/6J mice were obtained from Sankyo Labo Service
(Tokyo, Japan), and fed under standard conditions with food and
water ad libitum. All of the animal experiments were approved by
the Animal Care and Use Committee of Tokyo Medical and
Dental University.
Cell Culture Conditions
The mouse chondrogenic ATDC5 cell line was obtained from
the RIKEN cell bank (Tsukuba, Japan). Cells were maintained in
DMEM/F12 (1:1) medium containing 5% FCS, 10 mg/ml human
transferrin (Invitrogen A/S, Tastrup, Denmark), and 3610
28 M
sodium selenite (Sigma-Aldrich, Copenhagen, Denmark) at 37uC
in a humidified atmosphere containing 5% CO2. Chondrogenic
differentiation of ATDC5 cells was performed as previously
described [38]. Briefly, ATDC5 cells were seeded at a density of
6610
36cells/cm
2 in 6-well or 24-well plates and cultured for 4
days. When cells became confluent, the medium was replaced with
fresh medium supplemented with insulin (10 mg/ml).
Primary epiphyseal chondrocytes were isolated from 5-day-old
mice as previously reported [39]. Briefly, cartilage tissues,
including the femoral heads, femoral condyles and tibial plateau,
were cut into small pieces and digested twice for 45 min each with
3 mg/ml type I collagenase. Then, the cartilage pieces were
incubated in 0.5 mg/ml type I collagenase at 37uC in a thermal
incubator with 5% CO2 overnight. The next day, cell aggregates
were dispersed via pipetting. The cells were cultured in 12-well
plates with 5610
4 cells per well in DMEM/F12 medium contain-
ing 10% FBS and antibiotics.
RNA Extraction and Real-time RT-PCR
Total RNA was extracted from chondrocytes and cell lines
using TRIzol according to the manufacturer’s directions. Real-
time PCR was performed using the SuperScript III Platinum Two-
Step qRT-PCR Kit with SYBR Green on the Mx3000PH QPCR
System. Briefly, 0.5 mg total RNA was mixed with 10 ml2 6RT
reaction mix and 2 ml RT, and then incubated for 50 min at 42uC.
The reaction was terminated by heating for 5 min at 85uC. The
cDNA mixture was then incubated for 30 min at 37uC in the
presence of RNase H. The PCR reaction was carried out using
a mixture of Platinum SYBR Green qRT-PCR Super-Mix UDG,
the template cDNA, 10 mM of the primer mix, and DNase-free
H2O with a total volume of 20 ml per well. The cycling conditions
were performed as indicated in the Invitrogen SuperScript
TM III
Platinum two-step qRT-PCR kit with SYBR Green. Gene
expression was normalized to the endogenous control GAPDH,
and fold changes in the genes of interest were determined using the
comparative threshold cycle (Ct) method [40]. The qRT-PCR
primers are listed in Table 1.
Measurement of Cellular Injury
Primary chondrocytes were incubated at 37uC in 96-well plates.
After 2 days of culture, the medium was changed to 100 ml
DMEM/F12 supplemented with 10% FBS. Subsequently, the cells
were treated with H2O2,H 2O2+B3 or Tween 20, as a positive
control. After 24 h of culture, cellular injury was quantitated by
measuring lactate dehydrogenase (LDH) release using an LDH
Cytotoxicity Assay Kit (WAKO, Tokyo, Japan).
Surgical Induction of OA
Male mice (3 months old) were divided into two groups: B3 and
control (n=10 each). While the mice were under general
anesthesia, a medial capsular incision was made and the left knee
joint exposed. The medial collateral ligament was transected, and
the medial meniscus was removed using a surgical microscope
with a microsurgical technique, as previously reported [41]. The
Table 1. Primers for real-time PCR.
Forward 5 `-3 ` Reverse 5 `-3 `
Gapdh ACTCACGGCAAATTCAACGGC ATCACAAACATGGGGGCATCG
Aggrecan ATCAAGTGGAGCCGTGTTTC CTGGGGATGTCGCATAAAAG
iNOS GGATTTCAAAGACCTCTGGATC ATACTTTATGCCACCAACAATGG
Col1a1 CACCCTCAAGAGCCTGAGTC AGACGGCTGAGTAGGGAACA
Col2a1 CTGGCTGGCATCGTTAC AGAGTGGTTCCCCTGGTGAG
Col10a1 ACCAGGAATGCCTTGTTCTC ATGCTGAACGGGACCAAACG
doi:10.1371/journal.pone.0037728.t001
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allowed unrestricted activity and were provided food and water ad
libitum. None of the mice died during the experimental period. Five
days after surgery, B3 or the vehicle control was administered
orally (1 mg/10 g body weight) once a day.
Assessment of OA Severity
Whole knee joints were removed by dissection, fixed in 4%
paraformaldehyde, and decalcified in EDTA. After dehydration
and paraffin embedding, 5-mm frontal serial sections were cut from
the whole knee joint. Two sections were obtained at 100-mm
intervals and then stained with Safranin O–fast green and
haematoxylin and eosin. The OA severity in the tibial plateau
was evaluated according to Mankin’s histologic grading system
[42,43].
TUNEL Assay
The TUNEL assay was performed using a TUNEL detection
kit according to the manufacturer’s instructions (Takara Shuzo,
Kyoto, Japan). Briefly, knee joint sections were incubated with
15 mg/ml of proteinase K for 15 min at room temperature and
then washed with PBS. The sections were immersed in TdT
Enzyme diluted with Labeling Safe Buffer (provided in the kit) and
then incubated for 90 min at 37uC in a humid atmosphere. After
washing in PBS, the slides were examined by fluorescence
microscopy.
Immunohistochemistry
iNOS expression was examined by immunohistochemistry with
anti-mouse iNOS antibody used according to the manufacturer’s
instructions (Abcam Biochemicals, Cambridge, UK). Briefly, tissue
sections were incubated overnight at 4uC with a rabbit polyclonal
anti-mouse iNOS antibody, followed by a 30-min incubation at
room temperature with a biotinylated goat anti-rabbit IgG
antibody. Next, the signal was visualized using peroxidase-
conjugated avidin and diaminobenzidine from a Vectastain kit,
according to the manufacturer’s instructions (Vector Laboratories,
Burlingame, CA, USA).
Statistical Analysis
Data are expressed as the mean 6 SD. Statistical analysis was
performed with the Mann2Whitney U test or Bonferroni/Dunn
test. p values ,0.05 were considered significant.
Results
Effects of B3 on H2O2-induced Chondrocyte Apoptosis
The protective effects of B3 against H2O2-mediated chon-
drocyte cell death were evaluated in epiphyseal primary
chondrocytes. Cells were pre-incubated with increasing concen-
trations (5 and 50 mg/ml) of B3, and then treated with 500 mM
H2O2. Treatment with H2O2 induced apoptosis in approximate-
ly 60% of the cells after 24 h of treatment. However, pre-
incubating the cells with 5 and 50 mg/ml B3 significantly
reduced the extent of apoptosis in a dose-dependent manner
Figure 1. Phase contrast microscopy images of primary chondrocytes incubated with 500 mMH 2O2 and increasing concentrations
of B3 or vehicle control. The majority of H2O2 -treated cells were already detached and floating (b, asterisk), whereas control and B3-treated cells
had started rounding but mostly remained adherent (c, d, asterisk). Scale bar =200 mm. Cell viability of chondrocytes treated with H2O2 and B3 as
determined by the LDH assay (e). B3 prevented H2O2-induced chondrocyte apoptosis in a dose-dependent manner. Values represent the mean and
SD; n=5 samples/group. *p,0.05.
doi:10.1371/journal.pone.0037728.g001
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to the results of a pilot study. Anti-apoptotic effects of B3 were
observed from around 5 mg/ml to 1 mg/ml.
Effects of B3 on iNOS mRNA Expression in Chondrocytes
Primary chondrocytes were stimulated with 50 mMH 2O2 in
the absence or presence of increasing concentrations of B3, and
iNOS production was evaluated by real-time RT-PCR. B3
treatment suppressed H2O2-induced iNOS production
(Figure 2a). Similarly, iNOS production stimulated by 10 ng/
ml IL-1b was also suppressed in the presence of B3 (Figure 2b).
An LDH assay demonstrated that this inhibition was not due to
reduced cell viability (data not shown).
Effects of B3 on Chondrocyte ECM Synthesis
To investigate the effects of B3 on H2O2-induced reduction of
chondrocyte differentiation marker gene expression, primary
chondrocytes were stimulated with H2O2 in the absence or
presence of increasing concentrations of B3 for 24 h. B3 treatment
inhibited the H2O2-induced decrease in mRNA expression of
chondrocyte differentiation markers, including aggrecan and
Col2a1 (Figure 2c and d). By contrast, the expression of the
chondrocyte hypertrophy markers Col1a1 and Col10a1 was not
affected by B3 treatment (Figure 2e and f).
Next, we evaluated the effects of B3 on chondrocyte
differentiation using ATDC5 cells. ATDC5 cells were grown to
confluency and then cultured in differentiation medium. After 4
days, the cells were treated with B3 for 24 h. mRNA synthesis of
aggrecan and Col2a1, was significantly enhanced by B3
Figure 2. Effects of B3 on primary chondrocytes and ATDC5 cells. (a, b) B3 prevents H2O2- (a) or IL-1b(b)-induced iNOS synthesis. Primary
chondrocytes were stimulated with 50 mMH 2O2 in the absence or presence of increasing concentrations of B3 for 24 h. iNOS synthesis was assessed
by real-time RT-PCR. Each column represents the mean 6 SD of five separate experiments. *p,0.05. (c2f) B3 prevents H2O2-induced reduction of
proteoglycan (c) and Col2a1 (d) synthesis. Primary chondrocytes were stimulated with 50 mMH 2O2 in the absence or presence of 5 mg/ml B3 for 24 h.
mRNA expression of proteoglycan (c), Col2a1 (d), Col1a1 (e) and Col10a1 (f) was assessed by real-time RT-PCR. Results represent the mean 6 SEM of
three independent experiments. *p,0.05 (g2j) B3 enhances aggrecan and Col2a1 synthesis in ATDC5 cells. ATDC5 cells were incubated in DMEM/
F12 with 5%FBS. After the cells reached confluency, they were treated with differentiation medium. After 4 days of culture, the cells were treated with
B3 or the vehicle control for 24 h. mRNA expression of aggrecan (g), Col2a1 (h), Col1a1 (i) and Col10a1 (j) were determined by real-timeRT-PCR. The
results represent the mean 6 SEM from three independent experiments. *p,0.05.
doi:10.1371/journal.pone.0037728.g002
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expression was not affected (Figure 2i and j).
Prevention of Cartilage Destruction and Ectopic Cartilage
Formation by B3 Administration in a Surgically-induced
OA Model
To examine whether B3 prevents cartilage destruction, OA was
surgically induced in C57BL/6J mice, then B3 or a vehicle control
was orally administered. OA was induced by performing a medial
collateral ligament transection and medial meniscectomy on the
left knees; sham operations were performed on the right knees. B3
or the vehicle control was administered orally 5 days/week
beginning 5 days after the operation, and mice were euthanized 4
weeks after the operation. Histological examination revealed that
B3 administration markedly protected the articular cartilage from
proteoglycan depletion and prevented alterations in surface
structure (Figure 3Aa2d). The Mankin’s histologic OA grading
score in B3-treated animals was ,50% of the values in the control
group (p,0.05, Figure 3B).
In this OA model, the medial meniscus and medial collateral
ligament are surgically removed, followed by formation of
a pseudocapsule, which is composed of fibrous tissues. In control
OA mice, ectopic cartilaginous tissues were frequently observed in
the thick pseudocapsule as a result of chronic inflammation
(Figure 3Aa and e). By contrast, the thickness of the pseudocapsule
was markedly reduced in B3-treated mice along with a reduced
frequency of ectopic cartilage formation (Figure 3Ab and f, C and
D). These observations suggested that B3 suppressed chronic
inflammation in the surgical region.
Chondrocyte apoptosis is increased in OA cartilage [2,44].
These observations prompted us to investigate the effects of B3
administration on chondrocyte apoptosis. TUNEL-positive cells
were abundant among chondrocytes in the superficial layer of
articular cartilage in control mice with surgically-induced OA,
Figure 3. Histological analysis of surgically-induced osteoarthritis (OA) in the knee joints of mice after administering B3 or the
vehicle control. OA was surgically induced in 12-week-old mice, and the knee joints were harvested 4 weeks later. B3 or the vehicle alone (control)
was orally administered 5 times a week beginning 5 days after surgery and continuing until the end of the experiment (n=10). A, Representative
histologic features (a2d, Safranin O staining; e and f, H&E staining) of the knee joints of control (a, c, e) and B3-treated (b, d, f) mice. Degenerative
changes in the articular cartilage were ameliorated in B3-treated mice (b, d) as compared to controls (a, c). Note the thicker medial pseudocapsule in
the control group (a, b, arrows), and the ectopic cartilage formation in the pseudocapsule (a, asterisk). e, f, High magnification images of the
pseudocapsules. Note that the control pseudocapsule is occupied with hypertrophic chondrocyte-like cells (e), whereas only thin fibrous cells are
observed in B3-treated mice (f). B, Histological scoring of cartilage destruction according to Mankin’s score, * p,0.05. C, The thickness of the
pseudocapsule was significantly reduced in the B3-treated group. Values represent the mean 6 SD of 10 samples per group. *p,0.05. D, The
incidence of ectopic cartilage formation at the medial pseudocapsule was reduced by B3 treatment.
doi:10.1371/journal.pone.0037728.g003
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mice (Figure 4Aa and b). The number of TUNEL-positive
chondrocytes at the superficial layer of the joint cartilage in the
B3-treated group was almost one-third of that observed in the
control group (p,0.05, Figure 4B). These data indicated that the
antiapoptotic effects of B3 protected the articular cartilage.
To examine if B3 supplementation prevented cartilage de-
struction by inhibiting iNOS expression, immunohistological
analysis for iNOS was performed. iNOS protein expression was
enhanced in the synovial tissues and the pseudocapsule around the
surgical region in control mice (Figure 5a, arrows), whereas its
expression was reduced by B3 administration (Figure 5b). These
data indicated that B3 prevented aberrant articular cartilage
degeneration and heterotopic cartilage formation, at least in a part,
through suppression of iNOS in the OA model.
Discussion
Chondrocyte apoptosis has been implicated in the pathogenesis
of degenerative joint diseases, including osteoarthritis and rheu-
matoid arthritis [1,2,10]. H2O2 is both exogenously supplied and
endogenously produced in rheumatoid arthritis [1], and it can
induce chondrocyte apoptosis [10]. Thus, we used H2O2-treated
chondrocytes as an in vitro model to examine the ability of B3 to
prevent chondrocyte apoptosis. Indeed, B3 blocked H2O2-induced
chondrocyte apoptosis in vitro.
In this study, both H2O2 and the inflammatory cytokine IL-1ß
induced iNOS mRNA expression in chondrocytes, and B3
significantly suppressed iNOS mRNA expression arising from
both stimuli (Figure 2). The iNOS and NO levels in the synovial
uid and serum of patients with osteoarthritis are higher than those
in healthy individuals [45,46]. iNOS is expressed following
stimulation with a variety of inflammatory agents, such as
endotoxins or cytokines [47], and leads to the production of NO
in inammatory settings.
NO induces oxidative stress in chondrocytes, and as a result,
enhances aggrecan degradation and chondrocyte apoptosis [3,11].
NO also attenuates the synthesis of cartilage matrix proteins [48–
50]. In our study, H2O2 reduced mRNA synthesis of aggrecan and
Col2a1, which are cartilage differentiation markers, while B3
significantly prevented these negative effects.
In this study, B3 administration markedly prevented OA
progression in articular cartilage. Reduced progression of exper-
imental osteoarthritis is observed in vivo upon the selective
inhibition of iNOS [51]. Furthermore, selective inhibition of
iNOS reduces the progression of experimental osteoarthritis in vivo
[52]. In a collagen-induced arthritis model, joint pathology is
significantly inhibited in NOS-deficient mice [13]. These findings
are consistent with our observation that orally administered B3
prevents chondrocyte degeneration via regulating iNOS synthesis,
as shown in our surgically-induced OA model. Although B3-
mediated iNOS inhibition may be one means by which B3
prevents OA, the molecular target of B3 is still unknown.
Furthermore, TUNEL staining revealed that B3 suppressed
chondrocyte apoptosis in a mouse OA model. Many studies have
shown that apoptotic cell death occurs at an increased rate in
osteoarthritic cartilage, detrimentally impacting articular cartilage
maintenance. Combined with the in vitro data, this observation
may indicate that B3 had both antioxidant and anti-inflammatory
effects.
We also demonstrated that B3 treatment prevented heterotopic
cartilage formation near the surgical region, but enhanced the
differentiation of chondrocyte-like ATDC5 cells in vitro. This
discrepancy may be due to the effects of B3 on abnormal
inflammation at the pseudocapsule. In this study, ectopic cartilage
formation was triggered by the trauma of knee surgery, e.g.,
Figure 4. A. TUNEL staining of OA cartilage sections. TUNEL staining was examined by dark-field (a and b) and bright-field (c and d)
microscopy. The number of TUNEL-positive cells was increased in the superficial layer of joint cartilage in OA control mice (a), but was significantly
reduced in B3-treated mice (b). B, The number of TUNEL-positive cells in the superficial layer of articular cartilage as determined by fluorescence
microscopy. Values represent the mean 6 SD of 10 mice per group. *p,0.05 (Mann2Whitney U test).
doi:10.1371/journal.pone.0037728.g004
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a fibrous pseudocapsule was formed. In this location, a cascade of
chronic inflammation likely occurred as a result of joint instability.
In a typical cascade, iNOS is first expressed following stimulation
with a variety of inflammatory agents, such as endotoxins or
cytokines [47]. Then, NO promotes inflammation by enhancing
the production of inflammatory cytokines [53] and prostaglandins
[54]. The latter are implicated in the formation of heterotopic
bone [55]. On a related note, anthocyanins inhibit NF-kB
activation via TNF-a, resulting in the inhibition of VEGF
expression [56]. The NF-kB pathway is involved in regulating
prostaglandin expression via COX-2 activation [57,58]. Thus, B3
may prevent heterotopic ossification by inhibiting prostaglandin
activity through suppression of iNOS synthesis and inactivation of
the NF-kB pathway.
GSP have several bioactivities. They limit adipogenesis and
function as insulinomimetic, anti-inflammatory, and antioxidant
agents as shown in this study [32]. Dimeric and trimeric oligomers
are the most powerful procyanidin molecules that most closely
mimic complete GSP [32]. Grape seed extracts might be expected
to have same efficiency because they include several procyanidin
dimers and trimers in addition to B3, but additional experiments
will be required to confirm this hypothesis.
In conclusion, we have demonstrated that B3 prevented
cartilage destruction in an experimental murine model of OA
and heterotopic cartilage formation. Our results suggest that B3
prevented chondrocyte apoptosis by directly affecting chondro-
cytes in vivo. These results support the potential therapeutic
applications of B3 in humans with OA and HO.
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Figure 5. iNOS expression in a murine OA model. iNOS protein expression was enhanced in the synovial tissues and the pseudocapsule around
the surgical region in control mice (a, arrows), but was reduced in animals receiving B3 (b). iNOS expression and background levels were similar at the
lateral region of each knee joint in B3-treated (d) and control mice (c). sy, synovium; ps, pseudocapsule; lm, lateral meniscus; ta, tibial articular
cartilage.
doi:10.1371/journal.pone.0037728.g005
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